SV

Street Verdict

Analyst Scorecard

A record of what Ankush Bajaj said publicly, with the source. Not advice.

“Recommends buying Glenmark Pharmaceuticals today, September 10, at ₹2,116.30, targeting ₹2,149 with a stop loss at ₹2,099. The stock shows strong bullish momentum with RSI at 71.6, positive MACD (+32.6), and robust ADX (47.2), having broken out from a consolidation range.”

Ankush Bajaj’s track record (trackable calls only): 473 graded calls · 95% CI 39–48%

Glenmark Pharmaceuticals LtdBullishCalled 10 Sep 2025Graded 16 Sep 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹2,116.3, as stated.

Target ₹2,149, stop ₹2,099, as stated.

No time frame is stated, so it is tracked until a close reaches ₹2,149 or ₹2,099: there is no fixed window.

The stop ₹2,099 was reached on a close before the target ₹2,149. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹2116.3 on 2025-09-11 (stated entry ₹2116.3, LEVEL_CMP entry, filled); stop ₹2099 breached at close ₹2077 on 2025-09-16. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

How it played out

How this is worked out
Target or stop first
The stop was reached on a close before the target was.
Time to target
The target was not reached on a close before the stop was.
Worst close against it
The closing price went as far as 1.86% against the call up to 16 Sep 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Glenmark Pharmaceuticals Ltd since this call

1-year tracking window
Read the original articleSee Ankush Bajaj’s full track record